Main Menu
Main Menu
Stay updated with news and stories of strength and hope. Learn how biomarker testing is unlocking personalized treatment options and how clinical trials are offering new paths forward.
Let’s Talk About MGMT When you or a loved one is diagnosed with glioblastoma, it can feel like your world is turned upside down. Suddenly, you’re faced with urgent decisions, unfamiliar medical terms, and a whirlwind of emotions. One piece of information can help bring clarity: the tumor’s biomarkers. This blog post is part of the MyTumorID campaign, a […] July 8, 2025
When to Consider a Brain Tumor Clinical Trial A common misconception is that brain tumor clinical trials are only an option after multiple recurrences or as a last resort. In reality, there are five critical time points of eligibility, or windows of opportunity, when patients can consider brain tumor clinical trials — sometimes even before surgery or starting treatment. Because eligibility often depends […] May 19, 2025
Biomarker Testing Gave Julia Answers and the Confidence to Grow Her Family At 26, Julia was a new mom and five months postpartum when her world stopped: she had a brain tumor. After surgery, her health care team believed it was aggressive cancer. But thanks to biomarker testing, Julia’s path — and her prognosis — changed entirely. The Initial Diagnosis In 2019, Julia started experiencing strange, unsettling […] May 9, 2025
Laurence Talks About His Family’s Clinical Trial Experience Laurence’s wife, Julia, faced a brain tumor recurrence in 2021, and they searched for a clinical trial that would be their next best option. In this video, he shares their story and why clinical trials matter, not only to get an opportunity to participate in cutting-edge treatment but also to improve the science of patients […] April 15, 2025
Let’s Talk About Oligodendroglioma While oligodendroglioma is a relatively rare brain tumor, accounting for 1.2% of all primary brain tumors, an estimated 14,950 Americans are living with this tumor and navigating the unique challenges of this disease. Let’s talk about what makes oligodendrogliomas different from other brain tumors and the difficulties people living with this tumor type and their […] March 28, 2025
Have you undergone biomarker testing for your brain tumor or enrolled in a clinical trial? NBTS wants to hear from you!
This fall, join us for two free MyTumorID webinars designed to help patients and caregivers learn about biomarker testing (Sept. 26) and clinical trials (Oct. 24). Each session offers expert knowledge, firsthand insights, and resources to help you ask questions and make informed decisions about your treatment.
With MyTumorID, I decide.